GH – Guardant Health

Base Scores: Market & Sector: 138, Quality (Tech Proxies): 217, Near-Term Catalysts: 160, Technical Valuation: 143, Risks: 37
News: "Healthcare momentum; Tempus AI strengthens genomics leadership (+12)"
Final base score: 771
Valuation: P/E=N/A, PEG=N/A, Growth=YoY 0.39%
Certainty: 64%
ADVICE: [Buy]
Forecast image URL: https://stockscan.io/stocks/GH/forecast
What reduced the score: 58% above FVA (overextended), valuation history weak, ATR high, limited growth data.
What wasn't clear or contradictory: Breakout vs durability trade-off; lack of forward growth/valuation clarity.

VHC – VirnetX

Base Scores: Market & Sector: 138, Quality (Tech Proxies): 169, Near-Term Catalysts: 92, Technical Valuation: 253, Risks: 22
News: "N/A"
Final base score: 737
Valuation: P/E=13.01, PEG=0.28, Growth=YoY 47.00%
Certainty: 63%
ADVICE: [Buy]
Forecast image URL: https://stockscan.io/stocks/VHC/forecast
What reduced the score: Weak breadth/volume, flat RSI/MACD near-term, no near-term catalysts.
What wasn't clear or contradictory: Extremely low PEG without forward metrics; sustainability of growth not evidenced by recent tape.